Stay connected with colleagues and sign up for the
Learn more about HOPA's background
Learn more about
1 2 3 4
Stay connected with colleagues and sign up for the HOPA listserv here.
Learn more about HOPA's background visit the HOPA History Page
Learn more about HOPA Member Award winners.


Read HOPA’s comments to USP on proposed General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings.
Taskforce members who developed the comments included Ryan Forrey, PharmD MS FASHP (Associate Director, Pharmacy and Infusion Services, The James Cancer Hospital at The Ohio State University); Rich Cleveland, PharmD BCOP (Clinical Services Manager, Clinical Content and Pharmacy Operations, McKesson Specialty Health with the USOncology Network); and Susan Spivey, PharmD (The University of Texas M. D. Anderson Cancer Center).

Read a message from the HOPA President and Health Policy Committee Chair regarding HOPA’s response to the Provider Status and Medicare Coverage Initiatives.

New endured webinar Chemotherapy in Obese Patients and Amputees: Are Special Dosing Considerations Required? free recording now available. Earn 1.25 contact hours for a fee.

The calls for Completed Research and Trainee Research-In-Progress Poster Abstracts for the 2015 HOPA Annual Conference are now open.